Abstract
Background: Since December 2019, there has been an increasing number of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world. As of March 2020, the World Health Organization declared a global pandemic.
Case Presentation: To our best knowledge, this is the first report of a patient with SARS-CoV-2 infection presenting with constrictive pericarditis, possibly from the COVID infection. She was presented after a week of fever, persistent dry cough, and diarrhea. She received a single dose of hydroxychloroquine 400 mg, Oseltamivir 75 mg every 12 hours, lopinavir/ritonavir (Kaletra) 400/100 mg every 12 hours, and levofloxacin 750 mg daily. After 24 hours, she was immediately transferred to the Intensive Care Unit (ICU) because of dyspnea and progressive respiratory failure with a drop of the O2 saturation to 70%.
Conclusion: After a week of progress, her respiratory condition deteriorated again. She was re-admitted to the ICU and she expired. She died due to constrictive pericarditis, most probably caused by SARS-CoV-2.
Keywords: COVID-19, SARS-CoV-2, pneumonia, ARDS, pericarditis, cardiac tamponade.
Infectious Disorders - Drug Targets
Title:Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
Volume: 21 Issue: 7
Author(s): SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mehrnaz Asadi Gharabaghi and Fereshteh Ghiasvand*
Affiliation:
- Department of Infectious Diseases, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran,Iran
Keywords: COVID-19, SARS-CoV-2, pneumonia, ARDS, pericarditis, cardiac tamponade.
Abstract: Background: Since December 2019, there has been an increasing number of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world. As of March 2020, the World Health Organization declared a global pandemic.
Case Presentation: To our best knowledge, this is the first report of a patient with SARS-CoV-2 infection presenting with constrictive pericarditis, possibly from the COVID infection. She was presented after a week of fever, persistent dry cough, and diarrhea. She received a single dose of hydroxychloroquine 400 mg, Oseltamivir 75 mg every 12 hours, lopinavir/ritonavir (Kaletra) 400/100 mg every 12 hours, and levofloxacin 750 mg daily. After 24 hours, she was immediately transferred to the Intensive Care Unit (ICU) because of dyspnea and progressive respiratory failure with a drop of the O2 saturation to 70%.
Conclusion: After a week of progress, her respiratory condition deteriorated again. She was re-admitted to the ICU and she expired. She died due to constrictive pericarditis, most probably caused by SARS-CoV-2.
Export Options
About this article
Cite this article as:
SeyedAlinaghi SeyedAhmad , Ghadimi Maryam , Gharabaghi Asadi Mehrnaz and Ghiasvand Fereshteh*, Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report, Infectious Disorders - Drug Targets 2021; 21 (7) : e160921188928 . https://dx.doi.org/10.2174/1871526520666201209145001
DOI https://dx.doi.org/10.2174/1871526520666201209145001 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sudden Unexpected Death in Infancy (SUDI) — The Role of the Pathologist
Current Pediatric Reviews A Comprehensive Systemic Literature Review of Pericardial Decompression Syndrome: Often Unrecognized and Potentially Fatal Syndrome
Current Cardiology Reviews Why and How We Should Treat Elderly Patients with Hypertension?
Current Vascular Pharmacology Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Glucocorticoids and the Cardiovascular System: State of the Art
Current Pharmaceutical Design Cryoballoon Ablation of Atrial Fibrillation: State of the Art 10 Years After Its Invention
Recent Patents on Cardiovascular Drug Discovery Complications in Patients with Cardiac Penetrating Trauma
Cardiovascular & Hematological Disorders-Drug Targets Aortic Regurgitation as a Complication of Electrophysiologic Ablation Techniques: A Narrative Review
Current Cardiology Reviews Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Acute Severe Arterial Hypertension: Therapeutic Options
Current Drug Targets Descending Necrotizing Mediastinitis: Current Strategies for Diagnosis and Treatment
Current Respiratory Medicine Reviews Screening, Evaluation, and Early Management of Acute Aortic Dissection in the ED
Current Cardiology Reviews Management of Retained Intervention Guide-wire: A Literature Review
Current Cardiology Reviews Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease
Current Pharmaceutical Design Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: Meta-Analysis of Clinical Outcomes and Cost-Effectiveness
Current Pharmaceutical Design Association of Genetic Polymorphisms of CYP2C9 and VKORC1 with Bleeding Following Warfarin: A Case-Control Study
Current Clinical Pharmacology Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Current Cardiology Reviews Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit
Current Vascular Pharmacology Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events
Current Pharmaceutical Design Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews